Clinical Trial Update: Pembro Plus CAR T-cell Therapy in R/R in PMBCL [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating pembrolizumab in combination with CAR T-cell therapy for relapsed/refractory primary mediastinal large B-cell lymphoma is curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma
• Epstein-barr Virus-positive Diffuse Large B-cell Lymphoma
• Mediastinal Large B-cell Lymphoma
• T-cell Histiocyte-rich Large B-cell Lymphoma

Drugs mentioned

• CAR T-cell therapy (unspecified)
• Pembrolizumab (Keytruda) (pembrolizumab)

Snippet

Sponsor: Jennifer Crombie, MD | Conditions: Primary Mediastinal Large B-cell Lymphoma (PMBCL), Primary Mediastinal Large B Cell Lymphoma | Phase 2 | Status: RECRUITING